Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02016820 · ClinicalTrials.gov registry record · NA
Effect of Acid Suppression Medication on Pediatric Microbiome
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02016820: Clinical Trial NA study, sponsored by Columbia University.
NCT02016820 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02016820, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The colonic microbiome is essential in health and disease, and is highly dynamic during the first several years of life. Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely used in children, but the effects of PPIs and H2RAs on the pediatric colonic microbiome are unknown. This study will determine whether acid suppression with these medications affects the microbiome of otherwise healthy children who are prescribed acid suppression for gastroesophageal reflux disease (GERD), and determine the duration and magnitude of microbiome changes.
Interventions
- DRUG Omeprazole (suspension)
- OTHER Lifestyle Modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-01 |
| Phase | NA |
Why NCT02016820 stopped before completion
NCT02016820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Omeprazole (suspension) is the first listed.
NCT02016820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02016820 about?
NCT02016820 is a clinical study titled "Effect of Acid Suppression Medication on Pediatric Microbiome". The colonic microbiome is essential in health and disease, and is highly dynamic during the first several years of life. Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are widely used in children, but the effects of PPIs and H2RAs on the pediatric colonic microbiome are u...
What is the current status of trial NCT02016820?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2014-11. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02016820?
The interventions under investigation include: Omeprazole (suspension) (DRUG), Lifestyle Modification (OTHER).
Who is sponsoring clinical trial NCT02016820?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02016820's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia